Peregrine Pharmaceuticals (NASDAQ:PPHM), a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical companies and advancing its …
Roth Capital analyst Joseph Pantginis was out today with a research note on Peregrine Pharmaceuticals (NASDAQ:PPHM), after the drug-maker announced financial results for the fourth …
Peregrine Pharmaceuticals (NASDAQ:PPHM), a biopharmaceutical company committed to improving patient lives by delivering high quality biological products through its contract development and manufacturing organization …
Peregrine Pharmaceuticals (NASDAQ:PPHM), a biopharmaceutical company committed to improving patient lives by delivering high quality biological products through its contract development and manufacturing …
Galena Biopharma Inc FBR analyst Vernon Bernardino weighs in on Galena Biopharma Inc (NASDAQ:GALE), after the biotech company announced that the FDA has given Fast …
In a research report issued Friday, FBR analyst Thomas Yip reiterated an Outperform rating on shares of Peregrine Pharmaceuticals (NASDAQ:PPHM), with a $1.00 price target, …
Analyst Thomas Yip of FBR & Co is Bullish on biotech companies Peregrine Pharmaceuticals (NASDAQ:PPHM) and Cerus Corporation (NASDAQ:CERS). The analyst remains positive …
Peregrine Pharmaceuticals (NASDAQ:PPHM), a biopharmaceutical company focused on developing therapeutics to stimulate the body’s immune system to fight cancer, today announced financial results for …
Analysts are weighing in on biotechnology firms Peregrine Pharmaceuticals (NASDAQ:PPHM), Sarepta Therapeutics Inc (NASDAQ:SRPT), and Cara Therapeutics Inc (NASDAQ:CARA). Here’s a quick roundup of today’s …
Friday turned out to be a nightmare for shareholders of drug makers Peregrine Pharmaceuticals (NASDAQ:PPHM) and Cara Therapeutics Inc (NASDAQ:CARA), as the stocks price tumbled sharply in the wake …
